TrialFrontiers in immunology2022

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.

Daniel Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.